NOTE: The following Minutes are provided for informational purposes only.

If you would like to obtain an official copy of these Minutes, please contact

the State Board of Pharmacy at 614/466-4143 for instructions and fee.

STATE BOARD OF PHARMACY; 77 SOUTH HIGH STREET, ROOM 1702; COLUMBUS, OHIO 43215-6126

Tel: 614/466-4143 Fax: 614/752-4836 Eml: exec@bop.state.oh.us

Minutes Of The Meeting

Ohio State Board of Pharmacy

September 8, 9, 10, 2003

MONDAY, September 8, 2003

8:00 a.m.

ROLL CALL

The State Board of Pharmacy convened in Room East-B, 31st Floor, Vern Riffe Center for Government and the Arts, 77 South High Street, Columbus, Ohio with the following members present:

Robert P. Giacalone, R.Ph. (President); Lawrence J. Kost, R.Ph. (Vice-President); Diane C. Adelman, R.Ph.; Suzanne R. Eastman, R.Ph.; Elizabeth I. Gregg, R.Ph.; Nathan S. Lipsyc, R.Ph.; Dorothy S. Teater, Public Member; and James E. Turner, R.Ph.

Also present were William T. Winsley, Executive Director; Timothy Benedict, Assistant Executive Director; William McMillen, Licensing Administrator; Mark Keeley, Legislative Affairs Administrator; Robert Cole, Compliance Supervisor; David Rowland, Legal Affairs Administrator; and Sally Ann Steuk, Assistant Attorney General.

Mr. Rowland announced that the following settlement agreements had been signed by all parties and were now effective:

R-2004-037

SETTLEMENT AGREEMENT WITH THE STATE BOARD OF PHARMACY (Docket No. D-030109-053) In The Matter Of: DAVID L. RIEDER, R.Ph. 333 Belleview Avenue Chillicothe, Ohio 45601-3701 (R.Ph. No. 03-3-09634

This Settlement Agreement is entered into by and between David L. Rieder and the Ohio State Board of Pharmacy, a state agency charged with enforcing the Pharmacy Practice Act and Dangerous Drug Distribution Act, Chapter 4729. of the Ohio Revised Code. David L. Rieder voluntarily enters into this Agreement being fully informed of his rights afforded under Chapter 119. of the Ohio Revised Code, including the right to representation by counsel, the right to a formal adjudication hearing on the issues contained herein, and the right to appeal. David L. Rieder acknowledges that by entering into this agreement he has waived his rights under Chapter 119. of the Revised Code. Whereas, the Board is empowered by Section 4729.16 of the Ohio Revised Code to suspend, revoke, place on probation, refuse to grant or renew an identification card or enforce a monetary penalty on the license holder for violation of any of the enumerated grounds therein. Whereas, David L. Rieder is licensed to practice pharmacy in the State of Ohio. Whereas, on or about January 9, 2003, pursuant to Chapter 119. of the Ohio Revised Code, David L. Rieder was notified of the allegations or charges against him, his right to a hearing, his rights in such hearing, and his right to submit contentions in writing. David L. Rieder requested a hearing; it was scheduled and continued. The January 9, 2003, Notice of Opportunity for Hearing contains the following allegations or charges:

(1)	Records of the Board of Pharmacy indicate that David L. Rieder was originally licensed in the State of Ohio on July 27, 1970, pursuant to examination, and is currently licensed to practice pharmacy in the State of Ohio.
(2)	David L. Rieder did, from January 13, 2001, to September 23, 2001, by deception, procure the administration of, a prescription for, or the dispensing of a dangerous drug, to wit: David L. Rieder did, while working as a pharmacist at Kroger’s Pharmacy, fill the following unauthorized prescriptions for himself:

Rx No.	Date	Drug Type	Strength	Qty
6606574	01/13/01	Guaifen/PSE 600	60 mg	36
6607438	02/04/01	amoxicillin	500 mg	60
6607439	02/04/01	Guaifen/PSE 600	60 mg	115
6607937	02/17/01	amoxicillin	500 mg	30
6608200	02/24/01	naproxen	375 mg	57
6609199	03/28/01	loperamide	2 mg	60
6610133	05/08/01	naproxen	250 mg	60
6610683	06/04/01	naproxen	375 mg	60
6611110	06/23/01	Elimite Cream 5%		60
6611387	07/05/01	Methylprednisln DSPK	4 mg	21
6611387	07/30/01	Methylprednisln DSPK	4 mg	21
6612177	08/12/01	piroxicam	20 mg	18
6612891	09/04/01	Nalfon	300 mg	37
6613477	09/23/01	Ansaid	100 mg	100

	Such conduct is in violation of Section 2925.22 of the Ohio Revised Code.
(3)

(4)

David L. Rieder did, from July 1, 2000, through December 31, 2001, sell at retail dangerous drugs when the conduct was not in accordance with Chapters 4729. and 4731. of the Ohio Revised Code, to wit: without a prescription and without a legitimate medical purpose, David L. Rieder sold the following drugs to his mother:

Rx No.	Date	Drug Type	Strength	Qty
6600404	05/27/00	spironlactone	25 mg	60
6600404-refill	07/01/00	spironlactone	25 mg	60
6600404-refill	09/08/00	spironlactone	25 mg	60
6600404-refill	10/06/00	spironlactone	25 mg	60
6600404-refill	11/02/00	spironlactone	25 mg	60
6600404-refill	12/07/00	spironlactone	25 mg	60
6600404-refill	01/27/01	spironlactone	25 mg	60
6600404-refill	02/23/01	spironlactone	25 mg	60
6600404-refill	03/22/01	spironlactone	25 mg	60
6600404-refill	04/20/01	spironlactone	25 mg	60
6601781	07/01/00	Evista	60 mg	30
6602576	08/07/00	furosemide	40 mg	30
6602576-refill	09/20/00	furosemide	40 mg	30
6602576-refill	10/20/00	furosemide	40 mg	30
6602576-refill	10/26/00	furosemide	40 mg	30
6602576-refill	12/28/00	furosemide	40 mg	30
6602576-refill	02/23/01	furosemide	40 mg	30
6602576-refill	04/20/01	furosemide	40 mg	30
6602604	08/24/00	Zoloft	50 mg	30
6602604-refill	09/20/00	Zoloft	50 mg	30
6602604-refill	10/20/00	Zoloft	50 mg	30
6602604-refill	11/23/00	Zoloft	50 mg	30
6602604-refill	12/28/00	Zoloft	50 mg	30
6602604-refill	01/27/01	Zoloft	50 mg	30
6602604-refill	03/01/01	Zoloft	50 mg	30
6602604-refill	03/30/01	Zoloft	50 mg	30
6603507	09/17/00	Evista	60 mg	30
6603507-refill	10/12/00	Evista	60 mg	30
6603507-refill	11/09/00	Evista	60 mg	30
6603507-refill	02/01/01	Evista	60 mg	30
6603507-refill	03/01/01	Evista	60 mg	30
6603507-refill	03/30/01	Evista	60 mg	30